Preview
Heparin is used worldwide to prevent arterial and venous thrombosis and to treat established thromboembolic disorders. It is also the mainstay of anticoagulation therapy for cardiopulmonary bypass and hemodialysis circuits. In this article, the authors examine the common indications for heparin therapy and describe the basic principles of heparin monitoring. Use of low-molecular-weight heparin is also briefly reviewed.
Additional information
Notes on contributors
Brian R. Berry
Brian R. Berry, MD Steven Nantel, MD Dr Berry (pictured) is director of hematopathology, Greater Victoria Hospital Society, Victoria, British Columbia.
Steven Nantel
Dr Nantel is clinical assistant professor, department of medicine, division of hematology, Vancouver Hospital and Health Sciences Center.